Neoplasms, Esophageal Completed Phase 2 Trials for Fluorouracil (DB00544)

Also known as: Neoplasm, Esophageal / Esophageal Neoplasm / Esophageal Neoplasms / Oesophageal neoplasm / Esophageal neoplasm NOS / Oesophageal neoplasm NOS / Tumor of esophagus

IndicationStatusPhase
DBCOND0055130 (Neoplasms, Esophageal)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02128243Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric CancerTreatment
NCT01928290Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal CancerTreatment
NCT00054873Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric CancerTreatment
NCT00160030Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal CancerTreatment
NCT00259402Oxaliplatin in Esophagus Cancer (Advanced) 1st LineTreatment
NCT00390416Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal AdenocarcinomaTreatment
NCT00515216Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) TumorsTreatment